ID
25858
Description
Study ID: 101468/191 Clinical Study ID: SKF-101468/191 Study Title:A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Ropinirole in Subjects with Restless Legs Syndrome (RLS) Suffering from Periodic Leg Movements of Sleep (PLMS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Restless Legs Syndrome
Keywords
Versions (1)
- 9/22/17 9/22/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 22, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 CRF Tracking/Review Form (Form 24)
GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 CRF Tracking/Review Form (Form 24)
Description
CRF Tracking Review Form
Description
Screening to Study Conc.
Data type
text
Description
Screening to Study Conc. missing pages
Data type
integer
Description
RLS Rating Scales
Data type
text
Description
RLS Rating Scales: missing items
Data type
integer
Description
Patient Scales
Data type
text
Description
Patient Scales (missing pages)
Data type
integer
Description
Serious Adverse Experiences
Data type
text
Description
Serious Adverse Experiences (missing pages)
Data type
integer
Description
Form D
Data type
text
Description
Form D (missing pages)
Data type
integer
Description
Site Monitor´s comments
Data type
text
Description
Site Monitor´s Name
Data type
text
Description
Site Monitor´s Signature
Data type
text
Description
Date Submitted
Data type
date